Isolated Limb Perfusion With Melphalan and Tumor Necrosis Factor α for Advanced Melanoma and Soft-Tissue Sarcoma

By Hayes Andrew   Neuhaus Susan   Clark Matthew   Thomas J.  

Annals of Surgical Oncology, Vol. 14, Iss. 1, 2007-01 ,pp. : 230-238

Springer Publishing Company

Access to resources Recommend Favorite

Long-Term Locoregional Vascular Morbidity After Isolated Limb Perfusion and External-Beam Radiotherapy for Soft Tissue Sarcoma of the Extremity

By Hoven-Gondrie Miriam   Thijssens Katja   Dungen Jan   Loonstra Jan   Ginkel Robert   Hoekstra Harald  

Annals of Surgical Oncology, Vol. 14, Iss. 7, 2007-07 ,pp. : 2105-2112

Springer Publishing Company

Access to resources Recommend Favorite

Advanced Extremity Soft Tissue Sarcoma: Prognostic Effect of Isolated Limb Perfusion in a Series of 88 Patients Treated at a Single Institution

By Pennacchioli Elisabetta   Deraco Marcello   Mariani Luigi   Fiore Marco   Mussi Chiara   Collini Paola   Olmi Patrizia   Casali Paolo   Santinami Mario   Gronchi Alessandro  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 553-559

Springer Publishing Company

Access to resources Recommend Favorite

Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and sarcoma

By Moller Mecker   Lewis James   Dessureault Sophie   Zager Jonathan  

International Journal of Hyperthermia, Vol. 24, Iss. 3, 2008-01 ,pp. : 275-289

Informa Healthcare

Access to resources Recommend Favorite

Isolated Limb Perfusion with Tumor Necrosis Factor Alpha and Melphalan for Locally Advanced Soft Tissue Sarcoma: Three Time Periods at Risk for Amputation

By Ginkel Robert   Thijssens Katja   Pras Elisabeth   Graaf Winette   Suurmeijer Albert   Hoekstra Harald  

Annals of Surgical Oncology, Vol. 14, Iss. 4, 2007-04 ,pp. : 1499-1506

Springer Publishing Company

Access to resources Recommend Favorite